Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Concord Cancer Center provides comprehensive cancer care including advanced proton therapy, medical oncology, surgical oncology, and research. It operates as a flagship project for advanced radiotherapy in China and collaborates with leading institutions such as Sun Yat-sen University Cancer Center and MD Anderson Cancer Center. The center opened to patients in June 2021. Clinical results are not published as drug trials but the facility offers state-of-the-art technology for improved patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Concord Cancer Center.